Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model.

The bleeding disorder of hemophilia A currently treated by replacement therapy of the missing coagulation factor, factor VIII, is frequently complicated by the development of neutralizing antibodies. The therapeutic potential of attenuated forms of the lipid-associated glycoprotein tissue factor, a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Invest
Asıl Yazarlar: O'Brien, D P, Giles, A R, Tate, K M, Vehar, G A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 1988
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303495/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3134399/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113571
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller